Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating extracellular vesicles and small non-coding RNAs cargo in idiopathic inflammatory myopathies reveal differences across myositis subsets.
Franco C, Giannella A, Gasparotto M, Zanatta E, Ghirardello A, Pettorossi F, Rahmè Z, Depascale R, Ragno D, Bevilacqua G, Bellis E, Iaccarino L, Doria A, Ceolotto G, Gatto M. Franco C, et al. Among authors: bellis e. J Autoimmun. 2024 Jul;147:103255. doi: 10.1016/j.jaut.2024.103255. Epub 2024 May 25. J Autoimmun. 2024. PMID: 38788539 Free article.
Is per-protocol kidney biopsy required in lupus nephritis?
Parodis I, Moroni G, Calatroni M, Bellis E, Gatto M. Parodis I, et al. Among authors: bellis e. Autoimmun Rev. 2024 Jan;23(1):103422. doi: 10.1016/j.autrev.2023.103422. Epub 2023 Aug 24. Autoimmun Rev. 2024. PMID: 37633351 Review.
New onset sarcoidosis following biologic treatment in patients with seronegative inflammatory arthritis: A case series and systematic literature review.
Donzella D, Bellis E, Campisi P, Crepaldi G, Data V, Dapavo P, Lomater C, Marucco E, Saracco M, Gatto M, Iagnocco A. Donzella D, et al. Among authors: bellis e. Autoimmun Rev. 2024 Mar;23(3):103481. doi: 10.1016/j.autrev.2023.103481. Epub 2023 Nov 24. Autoimmun Rev. 2024. PMID: 38008299 Free article. Review.
Global Genotype by Environment Prediction Competition Reveals That Diverse Modeling Strategies Can Deliver Satisfactory Maize Yield Estimates.
Washburn JD, Varela JI, Xavier A, Chen Q, Ertl D, Gage JL, Holland JB, Lima DC, Romay MC, Lopez-Cruz M, de Los Campos G, Barber W, Zimmer C, Silva IT, Rocha F, Rincent R, Ali B, Hu H, Runcie DE, Gusev K, Slabodkin A, Bax P, Aubert J, Gangloff H, Mary-Huard T, Vanrenterghem T, Quesada-Traver C, Yates S, Ariza-Suárez D, Ulrich A, Wyler M, Kick DR, Bellis ES, Causey JL, Chavez ES, Wang Y, Piyush V, Fernando GD, Hu RK, Kumar R, Timon AJ, Venkatesh R, Abá KS, Chen H, Ranaweera T, Shiu SH, Wang P, Gordon MJ, Amos BK, Busato S, Perondi D, Gogna A, Psaroudakis D, Chen CPJ, Al-Mamun HA, Danilevicz MF, Upadhyaya SR, Edwards D, de Leon N. Washburn JD, et al. Among authors: bellis es. bioRxiv [Preprint]. 2024 Sep 19:2024.09.13.612969. doi: 10.1101/2024.09.13.612969. bioRxiv. 2024. PMID: 39345633 Free PMC article. Preprint.
Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax.
Cordella S, Giusti D, De Bellis E, Dargenio M, Creti' F, Lazzarotto D, Cattaneo C, Fracchiolla NS, Piccini M, Forghieri F, Pagano L, Candoni A. Cordella S, et al. Among authors: de bellis e. Hematol Oncol. 2024 Sep;42(5):e3310. doi: 10.1002/hon.3310. Hematol Oncol. 2024. PMID: 39276390 No abstract available.
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.
Lazzarotto D, Cerrano M, Papayannidis C, Chiaretti S, Mosna F, Fracchiolla N, Zappasodi P, Imbergamo S, Del Principe MI, Lunghi M, Lussana F, Piccini M, Fumagalli M, Dargenio M, Salutari P, Forghieri F, Da Molin TG, Bonifacio M, Olivi M, Giglio F, Trappolini S, Leoncin M, Mule A, Delia M, Pasciolla C, Grimaldi F, Cambo B, Santoro L, Guolo F, Minetto P, Defina M, Chiusolo P, Fanin M, Mauro E, Aprile L, Mazzone C, Trastulli F, Ciccone M, De Gobbi M, Cignetti A, De Bellis E, Mancini V, Piciocchi A, Vignetti M, Marsili G, Starza ID, Fanin R, Luppi M, Ferrara F, Pizzolo G, Bassan R, Foa R, Candoni A. Lazzarotto D, et al. Among authors: de bellis e. Haematologica. 2024 Aug 15. doi: 10.3324/haematol.2024.285638. Online ahead of print. Haematologica. 2024. PMID: 39157875 Free article.
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus.
Ruscitti P, Allanore Y, Baldini C, Barilaro G, Bartoloni Bocci E, Bearzi P, Bellis E, Berardicurti O, Biaggi A, Bombardieri M, Cantarini L, Cantatore FP, Caporali R, Caso F, Cervera R, Ciccia F, Cipriani P, Chatzis L, Colafrancesco S, Conti F, Corberi E, Costa L, Currado D, Cutolo M, D'Angelo S, Del Galdo F, Di Cola I, Di Donato S, Distler O, D'Onofrio B, Doria A, Fautrel B, Fasano S, Feist E, Fisher BA, Gabini M, Gandolfo S, Gatto M, Genovali I, Gerli R, Grembiale RD, Guggino G, Hoffmann-Vold AM, Iagnocco A, Iaquinta FS, Liakouli V, Manoussakis MN, Marino A, Mauro D, Montecucco C, Mosca M, Naty S, Navarini L, Occhialini D, Orefice V, Perosa F, Perricone C, Pilato A, Pitzalis C, Pontarini E, Prete M, Priori R, Rivellese F, Sarzi-Puttini P, Scarpa R, Sebastiani G, Selmi C, Shoenfeld Y, Triolo G, Trunfio F, Yan Q, Tzioufas AG, Giacomelli R. Ruscitti P, et al. Among authors: bellis e. Autoimmun Rev. 2024 Jul-Aug;23(7-8):103581. doi: 10.1016/j.autrev.2024.103581. Epub 2024 Jul 26. Autoimmun Rev. 2024. PMID: 39069240
Retention Rate of Ixekizumab in Psoriatic Arthritis: A Real-World Study.
Bellis E, Ruscitti P, Donzella D, Crepaldi G, Data V, Gammino M, Gatto M, Guardo V, Lomater C, Marucco E, Saracco M, Iagnocco A. Bellis E, et al. J Pers Med. 2024 Jul 3;14(7):716. doi: 10.3390/jpm14070716. J Pers Med. 2024. PMID: 39063970 Free PMC article.
132 results